EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome

Xuehong Deng iD, Lin Xiao, Mei Luo iD, Peiwei Xie, Lishou Xiong

Journal of Gastroenterology and Hepatology · 2023-07 · 38 (7) · 1072-1082

DOI: 10.1111/jgh.16159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 15.03.2023. Verfasst von Xuehong Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Microbiota, Gastrointestinal Microbiome, Gastrointestinal Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome (IBS) is a relatively common functional gastrointestinal disease with a disturbance of intestinal bacteria. Bile acids, gut microbiota, and the host have close and complex interactions, which play a central role in modulating host immune and metabolic homeostasis. Recent studies suggested that the bile acid–gut microbiota axis played a key role in the development of IBS patients. In order to investigate the role of bile acids in the pathogenesis of IBS and present potentially relevant clinical implications, we conducted a literature search on intestinal interactions between bile acid and gut microbiota. The intestinal crosstalk between bile acids and gut microbiota shapes the compositional and functional alterations in IBS, manifesting as gut microbial dysbiosis, disturbed bile acid pathway, and alteration of the microbial metabolites. Collaboratively, bile acid conducts the pathogenesis of IBS through the alterations of the farnesoid‐X receptor and G protein‐coupled receptor. Diagnostic markers and treatments targeting the bile acids and its receptor showed promising potential in the management of IBS. Bile acids and gut microbiota play a key role in the development of IBS and make attractive biomarkers for treatments. Individualized therapy aiming at bile acids and its receptor may provide significant diagnostic and requires further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeMicrobiotaGastrointestinal MicrobiomeGastrointestinal DiseasesHumansBile Acids and Salts

Stichwörter der Autor:innen

FXRTGR5bile acidsgut microbiotairritable bowel syndrome

Substanzen

Bile Acids and Salts

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

ORCID-Profile: Xuehong Deng, Mei Luo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Deng, X., Xiao, L., Luo, M., Xie, P., & Xiong, L. (2023). Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 38(7), 1072-1082. https://doi.org/10.1111/jgh.16159

Vancouver

Deng X, Xiao L, Luo M, Xie P, Xiong L. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome. Journal of Gastroenterology and Hepatology. 2023;38(7):1072-1082. doi:10.1111/jgh.16159

BibTeX
@article{Deng2023,
  author = {Deng, Xuehong and Xiao, Lin and Luo, Mei and Xie, Peiwei and Xiong, Lishou},
  title = {Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  volume = {38},
  number = {7},
  pages = {1072--1082},
  doi = {10.1111/jgh.16159}
}
Kostenlos starten →